These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9008463)

  • 1. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK; Kent KM; Mehran R; Mintz GS; Tio FO; Foegh M; Wong SC; Cathapermal SS; Leon MB
    Circulation; 1997 Jan; 95(2):449-54. PubMed ID: 9008463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK; Kent KM; Tio FO; Foegh M; Kornowski R; Bramwell O; Cathapermal SS; Leon MB
    Coron Artery Dis; 1997 Feb; 8(2):101-4. PubMed ID: 9211050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saline infusion via local drug delivery catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Kim WH; Hong MK; Kornowski R; Tio FO; Leon MB
    Coron Artery Dis; 1999 Dec; 10(8):629-32. PubMed ID: 10599542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis.
    Kornowski R; Hong MK; Tio FO; Choi SK; Bramwell O; Leon MB
    Coron Artery Dis; 1997 May; 8(5):293-8. PubMed ID: 9285182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Kwok OH; Chow WH; Law TC; Chiu A; Ng W; Lam WF; Hong MK; Popma JJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):541-6. PubMed ID: 16208695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries.
    Santoian ED; Schneider JE; Gravanis MB; Foegh M; Tarazona N; Cipolla GD; King SB
    Circulation; 1993 Jul; 88(1):11-4. PubMed ID: 8100489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.
    Eriksen UH; Amtorp O; Bagger JP; Emanuelsson H; Foegh M; Henningsen P; Saunamäki K; Schaeffer M; Thayssen P; Orskov H
    Am Heart J; 1995 Jul; 130(1):1-8. PubMed ID: 7611096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
    Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
    Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
    Dussaillant GR; Mintz GS; Pichard AD; Kent KM; Satler LF; Popma JJ; Wong SC; Leon MB
    J Am Coll Cardiol; 1995 Sep; 26(3):720-4. PubMed ID: 7642865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study.
    Meneveau N; Schiele F; Grollier G; Farah B; Lablanche JM; Khalifé K; Machecourt J; Danchin N; Wolf JE; Simpson M; Hak JB; Bassand JP
    Eur Heart J; 2000 Nov; 21(21):1767-75. PubMed ID: 11052841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries.
    Armstrong J; Gunn J; Arnold N; Malik N; Chan KH; Vick T; Stratford P; Cumberland DC; Holt CM
    J Invasive Cardiol; 2002 May; 14(5):230-8. PubMed ID: 11983942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation.
    Bauters C; Van Belle E; Wernert N; Delcayre C; Thomas F; Dupuis B; Lablanche JM; Bertrand ME; Swynghedauw B
    Circulation; 1994 May; 89(5):2327-31. PubMed ID: 7910119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group.
    Emanuelsson H; Beatt KJ; Bagger JP; Balcon R; Heikkilä J; Piessens J; Schaeffer M; Suryapranata H; Foegh M
    Circulation; 1995 Mar; 91(6):1689-96. PubMed ID: 7882475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study].
    Eriksen UH; Amtorp O; Bagger JP; Emanuelsson H; Foegh M; Saunamäki KI; Schaeffer M; Thayssen P; Orskov H; Kuntz RE; Popma JJ
    Ugeskr Laeger; 1996 Nov; 158(46):6605-8. PubMed ID: 8966826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-1beta convertase is associated with decrease of neointimal hyperplasia after coronary artery stenting in pigs.
    Gyöngyösi M; Sperker W; Csonka C; Bonderman D; Lang I; Strehblow C; Adlbrecht C; Shirazi M; Windberger U; Marlovits S; Gottsauner-Wolf M; Wexberg P; Kockx M; Ferdinandy P; Glogar D
    Mol Cell Biochem; 2003 Jul; 249(1-2):39-43. PubMed ID: 12956396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model.
    Russo RJ; Silva PD; Yeager M
    Heart; 2007 Dec; 93(12):1609-15. PubMed ID: 17639098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model.
    McKenna CJ; Burke SE; Opgenorth TJ; Padley RJ; Camrud LJ; Camrud AR; Johnson J; Carlson PJ; Lerman A; Holmes DR; Schwartz RS
    Circulation; 1998 Jun; 97(25):2551-6. PubMed ID: 9657476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.